Surmodics (FRA:SU6) Long-Term Debt : €28.3 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Surmodics Long-Term Debt?

Surmodics's Long-Term Debt for the quarter that ended in Dec. 2024 was €28.3 Mil.

Surmodics's quarterly Long-Term Debt declined from Jun. 2024 (€27.4 Mil) to Sep. 2024 (€26.6 Mil) but then increased from Sep. 2024 (€26.6 Mil) to Dec. 2024 (€28.3 Mil).

Surmodics's annual Long-Term Debt increased from Sep. 2022 (€0.0 Mil) to Sep. 2023 (€27.6 Mil) but then declined from Sep. 2023 (€27.6 Mil) to Sep. 2024 (€26.6 Mil).

Surmodics Long-Term Debt Historical Data

The historical data trend for Surmodics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Long-Term Debt Chart

Surmodics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Long-Term Debt

Get a 7-Day Free Trial

27.55

26.63

Surmodics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															27.00	27.12	27.42	26.63	28.26

Surmodics (FRA:SU6) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Surmodics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Surmodics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Surmodics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (FRA:SU6) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SRDX:USA

Address

9924 West 74th Street, Eden Prairie, MN, USA, 55344

Website

https://www.surmodics.com

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Surmodics Headlines

No Headlines